European Hormone Day

by Catriona Taylor | May 15, 2023 | Growth Hormone, Growth Hormone Deficiency, Information, News

Today is European Hormone Day. A dedicated day bringing together the European endocrine community to raise awareness.

You can access our information about conditions we support, including Growth Hormone Deficiency, Primary IGF-1 Deficiency, Hypopituitarism and Precocious Puberty, here on our website where we have a range of information pages and booklets, along with some great video resources from our Growth Nurse Specialist Sally over on our YouTube channel www.youtube.com/@childgrowthfoundation.

Need to speak to someone? We are here to listen and support you. Call our support line on 020 8995 0257 or email us at [email protected].

For more support and resources you can visit ‘You and your hormones‘, an online education resource from the Society for Endocrinology. You can also find out about other European Hormone Day plans on the European Society of Endocrinology website.

PenCycle

by Neil Hunter | Nov 2, 2021 | Growth Hormone, Growth Hormone Deficiency, News

Reclycing Initiative Launched by Novo Nordisk

PenCycle is the exciting new environmental initiative by Novo Nordisk which aims to drastically reduce the amount of waste produced by pre-filled medication pens.

As part of their ‘Circular for Zero’ environmental change policy, they have created a recycling scheme for the pens, which includes their pre-filled growth hormone pen, which will help reduce the 23 million pens currently going into landfill or being incinerated each year.

The plan is simple, instead of placing your empty pen in the sharps bin, take the needle off and put the rest of the pen into the PenCycle box (the needle goes in your sharps bin as usual). The Pencycle box will be delivered to you through your Alcura service and Alcura will take the box away when it is full.

The pens will then avoid landfill and may then be recycled into chairs or light bulbs.

The pilot scheme will run for 6 months initially, in a small number of areas using the Alcura delivery servie. During the pilot Novo Nordisk are looking for a 30% uptake to the scheme, and then will then decide how to roll the programme out further.

To find out more download the PENCYCLE leaflet

or visit the growth hormone pre-filled pen WEBPAGE

European Hormone Day

PenCycle

Reclycing Initiative Launched by Novo Nordisk

Other Conditions

e-News Sign Up

European Hormone Day

PenCycle

Reclycing Initiative Launched by Novo Nordisk

Other Conditions

e-News Sign Up

Subscribe